A simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study reports.

A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease.

The parents of Kelly Turner, Linda and Martin, recently visited The Institute of Cancer Research, London, to see the labs doing research into the cancer that took Kelly’s life.